During the past decade, West Virginia University Eye Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Virginia University Eye Institute" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "West Virginia University" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Hermann Eye Center" with 1 trials sponsored and "Immunovant Sciences GmbH" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Virginia University Eye Institute" #1 collaborator was "Alcon Research" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "West Virginia University Eye Institute" are "Diabetic Macular Edema" (4 trials), "Glaucoma" (4 trials), "Geographic Atrophy" (3 trials), "Central Retinal Vein Occlusion" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "West Virginia University Eye Institute" in a lesser frequency.

Most popular intervention types in "West Virginia University Eye Institute" are "Drug" (14 trials), "Other" (7 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "West Virginia University Eye Institute" are 19 trials for "All" genders.

Currently, there are NaN active trials in "West Virginia University Eye Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in West Virginia University Eye Institute, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in West Virginia University Eye Institute, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".